Respiratory Syncytial Virus Therapeutics Market – By Drugs Type (Palivizumab, Ribavirin, Motavizumab), Route of administration (Oral, Injectable, Intranasal), Patient Type (Adult, Pediatric), Distribution Channel & Forecast, 2024 – 2032
Published on: 2024-07-10 | No of Pages : 240 | Industry : Healthcare
Publisher : MIR | Format : PDF&Excel